Data Readiness: The Unglamorous Work That Decides Whether AI Works

Most failed AI initiatives in drug discovery and biomanufacturing do not die because of flawed model architectures or insufficient computing power. They fail because the underlying data is a chaotic assemblage of disconnected spreadsheets, inconsistent sample labels, and unannotated instrument outputs. While executive presentations focus on foundational models and predictive transformers, the day-to-day reality of machine learning in the life sciences remains an exercise in data archaeology. Until biopharma leaders address the plumbing beneath their research operations, advanced algorithms will continue to yield disappointing results or expensive hallucinations.

The Silo Problem: ELN, LIMS, and Unstructured Drift

In a typical R&D organization, operational data lives across multiple disconnected systems. Electronic Lab Notebooks (ELNs) hold narrative experiment logs and embedded tables. Laboratory Information Management Systems (LIMS) track sample inventories and execution workflows. Chromatography data systems, imaging repositories, and local network drives hold the raw measurement files.

Because these systems were usually acquired piecemeal or introduced across different departments over several years, they rarely share a unified data schema. A compound identifier in an ELN entry may not match the inventory barcode registered in the LIMS. Worse still, crucial context, such as instrument calibration status, buffer batch numbers, or centrifugation duration, often exists only as free text in a lab notebook entry, if it is recorded at all. When computational scientists attempt to pool these sources to train a predictive model, they spend months writing fragile extraction scripts that break whenever a vendor updates a schema or an operator changes a naming convention.

Ontologies and Unique Identifiers

Fixing fragmentation requires foundational discipline around identifiers and controlled vocabularies. Without globally unique, persistent identifiers for every entity—compounds, target proteins, cell lines, assays, and physical containers—machine learning models cannot reliably join datasets.

Organizations often rely on ad-hoc internal naming schemes that drift across research sites. A single target protein might appear under three different synonyms across assay panels, blinding a model to common activity patterns. Adopting standard public ontologies, such as ChEBI for chemical entities, the NCBI Taxonomy for organisms, and the Assay Ontology for experimental conditions, establishes a clear, machine-readable baseline.

Implementing standard ontologies does not require an immediate enterprise-wide re-indexing of every legacy record. Instead, teams commonly focus on mapping core entities at the point of ingestion, establishing strict validation rules that prevent non-standard identifiers from entering primary databases.

Bench-Level Metadata Capture

The quality of an AI model is capped by the quality of the metadata captured at the bench. When scientists view metadata entry as an administrative burden, compliance degrades, resulting in blank fields, placeholder text, and inconsistent units of measure.

Automating metadata capture at the instrument level is an effective way to reduce human error. Modern analytical equipment can automatically broadcast run parameters, ambient temperature, and execution timestamps alongside raw data files. Where manual entry remains necessary, interface design should enforce structural constraints, such as dropdown lists constrained by ontologies, mandatory fields for critical process parameters, and automated unit conversions, without creating friction for bench scientists.

Metadata capture should also encompass context regarding negative results. Machine learning models require balanced training sets; if unpromising assay runs or failed purifications are routinely omitted from official logs, models will inherit an exaggerated bias toward success, limiting their real-world accuracy.

Data Lineage and Provenance

Data lineage refers to the complete record of a dataset's origin, transformations, and movements over time. For machine learning applications in bioprocessing or discovery, provenance allows practitioners to trace a prediction back to the specific raw instrument runs and pre-processing steps that produced the training inputs.

Without robust data lineage, troubleshooting anomalous model outputs becomes nearly impossible. If an algorithm suddenly predicts an unusual drop in expression yield, computational teams must be able to verify whether the shift reflects genuine biological variation or an unrecorded change in media preparation protocols.

Establishing clear provenance records may support, but does not satisfy, regulatory expectations or GxP validation requirements. Operating leaders should ensure that lineage tracking systems align with their internal Quality Management System (QMS) and standard operating procedures, working directly with quality units before relying on automated pipelines for decision-making in regulated environments.

A Staged Data Readiness Framework

To move from passive acknowledgment of data issues to structured remediation, leadership can execute a focused framework over a single quarter. This staged assessment evaluates current infrastructure against realistic computational requirements across four distinct phases.

• Days 1 to 30 (Inventory and Mapping): Audit existing data assets within a target domain. Identify all software applications, local drives, and physical registries housing relevant records. Map the flow of data from instrument generation to terminal storage, flagging manual copy-paste steps and custom conversion scripts.
• Days 31 to 60 (Schema and Identifier Audit): Evaluate entity naming consistency across systems. Assess the rate of sample tracking discrepancies, missing metadata fields, and duplicate records. Evaluate alignment with recognized public ontologies.
• Days 61 to 75 (Gap Quantification and Risk Scoring): Classify data quality issues based on their potential impact on downstream computational pipelines. Determine whether missing information represents a structural blocker or manageable noise.
• Days 76 to 90 (Remediation Strategy and Sequencing): Develop a prioritized roadmap for targeted data engineering. Define clear success metrics and assign ownership for schema enforcement and pipeline maintenance.

Sequencing Fixes to Scientific Decisions

A common trap for operating leaders is attempting an all-at-once data cleanup before launching any computational work. These multi-year data cleanup programs rarely succeed; they consume significant resources while losing touch with operational priorities.

A more pragmatic approach sequences data remediation around specific, high-value scientific decisions. If an organization aims to use predictive models to optimize lead compound selection, data readiness efforts should focus exclusively on the assays, physical inventories, and chemical registries tied to that specific pipeline phase.

By scoping cleanup efforts to immediate decision nodes, teams build reusable infrastructure, such as validated schemas and automated ingestion pipelines, that can be extended to adjacent domains in subsequent iterations. This iterative approach demonstrates measurable value early while incrementally raising the organization's overall data maturity. Ultimately, data readiness is an ongoing operational discipline subject to an organization's specific SOPs and quality requirements, rather than a one-time IT overhaul.

How it works in practice

Data readiness is easier to understand once you see what a model actually consumes. A trained model does not read your ELN; it reads a table, and that table has to be built.

• What data goes in. One row per unit of analysis — a run, a batch, a sample, a subject — with columns for every input the model is allowed to see, joined from ELN, LIMS, instrument exports and the process historian. Readiness work is almost entirely the work of making that join possible and correct.
• What the model predicts or ranks. Whatever the target column holds: yield, purity, pass or fail, time to result. If the target cannot be stated as a single well-defined column, the project is not ready to start.
• Technique or model family. Deliberately unremarkable at this stage — regression or gradient-boosted trees on the assembled table. The point of a readiness project is that the modelling step becomes the easy part.
• How it is trained or validated. Held out by batch, site or time, and validated first against a trivial baseline such as the historical mean. A model that cannot beat the baseline is usually telling you the table is missing the variables that actually drive the outcome.
• What the team does with the output. Two things: an early read on whether the signal exists at all, and a concrete list of the fields that need better capture at the bench before the next attempt.
• A representative example. Input: 340 historical runs joined across ELN and the historian, with 40 percent missing raw-material lot identifiers. Output: a model that beats the baseline only on the 60 percent of rows with lot data. The finding is not the model — it is that lot capture must be fixed at source.

Sources

1. The FAIR Guiding Principles for scientific data management and stewardship — Wilkinson et al., Scientific Data, 2016.
2. OMOP Common Data Model — Observational Health Data Sciences and Informatics.
3. AI Risk Management Framework (AI RMF 1.0) — National Institute of Standards and Technology.